current mainstay of treatment for human immunodeficiency virus (hiv)-infected patients is highly active antiretroviral therapy (haart) but little is known about the long-term clinical outcome for hiv-infected patients who have received haart. determining factors associated with longterm survival in the course of treatment may allow modification to be made for patients who are at a greater risk ...

it is estimated globally 3.2 million children were living with hiv in 2014, that mostly in sub-saharan africa. however, the majority of them infected to hiv from their mothers during pregnancy, during delivery or breastfeeding (1). antiretroviral therapy (art) use during and after pregnancy is essential for prevention of mother-to-child transmission (pmtct) of hiv (2).  in the absence of any in...

there are limited documents about hiv patients switched to second-line antiretroviral therapy (art) in resource-limited countries. we aimed to assess the efficacy of second-line art for hiv patients following first-line art failure. this was a cohort study of hiv/aids patients with first-line art treatment failure switched to second-line art between january 2004 and march 2014, who followed for...

background and objective: dyslipidemia has become a common problem in human immunodeficiency virus (hiv) disease, especially in patients on combination antiretroviral therapy. in this study we aimed to determine the prevalence of dyslipidemia and metabolic abnormalities in 2 groups of hiv infected patients receiving highly active antiretroviral therapy (haart) and antiretroviral-naive patients....

pulmonary hypertension is rare but is one of the complications that occur due to hiv infection. symptoms of hiv-associated pulmonary arterial hypertension are often non-specific but the main symptom of the disease is dyspnea. in this cross-sectional study, we measured systolic pulmonary arterial pressure (spap) by echocardiographic methods among hiv-positive patients who received art. this rese...

case presentation a 52-year-old malay gentleman, with hepatitis c virus and hiv infection was admitted to the intensive care unit for severe lactic acidosis, with concurrent escherichia coli bacteremia with multiorgan dysfunction. the patient was started on highly active antiretroviral therapy, which included tenofovir, 5 weeks before presentation. antimicrobial therapy, continuous veno-venous ...

dyslipidemia has become a common problem in human immunodeficiency virus (hiv) disease, especially in patients on combination antiretroviral therapy. we investigated the prevalence of and factors associated with dyslipidemia in hiv-infected patients in iran. in this cross-sectional study, 190 hiv positive patients who referring to behavioral disease consulting centers (shemiranat, varamin) and ...

Currently, there are about 37 million people worldwide living with human immunodeficiency virus (HIV) /AIDS, with an estimated two million new cases per year globally. According to estimates from the World Health Organization (WHO), only 75% of the population with HIV know their status. Initially, HIV infection was associated with significantly increased rates of mortality and morbidity. Howeve...

bone disorders have emerged as a worrisome complication in hiv-infected patients in recent years. it is not clear that hiv infection itself or antiretroviral treatment or both are causes of bone loss. however, most studies have found a high prevalence of osteopenia and osteoporosis in hiv/aids patients. the objectives of this study were to determine the prevalence of osteopenia and osteoporosis...